Glenda Gray

University of the Witwatersrand Perinatal HIV Research Unit

Glenda Gray, MBBCH, FCPaeds (SA) is the executive director of the Perinatal HIV Research Unit and Associate Professor of Pediatrics, University of the Witwatersrand, South Africa and Director of HVTN Africa Programs. She is based at the Chris Hani Baragwanath Hospital, in Soweto, South Africa where she is the Principal Investigator of the Soweto Clinical Trials Unit.

She has expertise in the field of mother to child transmission of HIV, adolescent HIV prevention and treatment and HIV vaccine and microbicide research. She received the Femina "Woman of the Nineties" Award, for her contribution to Perinatal HIV Research. In 2002, she was awarded the Nelson Mandela Health and Human Rights Award for pioneering work done in the field of Mother-to-Child Transmission of HIV-1. Glenda was awarded the IAPAC "Hero of Medicine" award for work done in the field of HIV treatment in children and adults.

Glenda became involved in HIV Vaccine research in 2000, and lead the first clinical trials involving HIV Vaccines in RSA. She was the Protocol Chair for the first phase IIB HIV vaccine trial to be conducted in sub-Saharan Africa and was in charge of the early clinical development of South Africa's first two candidate DNA and MVA HIV vaccines, which have been tested in both the USA and RSA under FDA and MCC regulations. She was the International Vice Chair for Vaccines for the NIH funded IMPAACT network until 2010. 

Glenda also serves as a member of the DCP3 Advisory Committee to the Editors